AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

17 recruiting trials

for Chronic Kidney Disease Requiring Chronic Dialysis

Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease. NCT05266092n/a1 site๐Ÿ“ Odense Odense University Hospital ยท Tests: Observational study Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation NCT06591702n/a1 site๐Ÿ“ Ankara Hacettepe University ยท Tests: Questionnaire study Post-market Surveillance Study of the BDยฎ WavelinQโ„ข EndoAVF System NCT04634916NA17 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco๐Ÿ“ Jacksonville C. R. Bard ยท Tests: EndoAVF Creation A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia NCT06712654Phase 231 sites๐Ÿ“ Huntsville๐Ÿ“ Chula Vista๐Ÿ“ Los Angeles R1 Therapeutics ยท Tests: AP306 75 mg BID, AP306 125 mg BID, AP306 150 mg BID, AP306 75 mg TID, AP306 100 mg TID Impact of Dialysis on Sexuality. NCT07332949n/a1 site๐Ÿ“ Neuilly-sur-Seine CMC Ambroise Parรฉ ยท Tests: Questionnaire on sexuality Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients NCT07710183NA1 site๐Ÿ“ Baghdad Al-Mustansiriyah University ยท Tests: Pumpkin Seed Oil 1000 mg, Standard hemodialysis care Smart and Fit for Kidney Transplantation NCT06040281NA1 site๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School ยท Tests: intensive individual support in nutrition and exercise, Usual Care DIALysis With EXpanded Solute Removal NCT06660277NA3 sites๐Ÿ“ London๐Ÿ“ Orillia๐Ÿ“ Ottawa London Health Sciences Centre Research Institute OR Lawson โ€ฆ ยท Tests: Super High-Flux Dialyzer, High-Flux Dialyzer Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients NCT06873880n/a1 site๐Ÿ“ Tartu University of Tartu Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension NCT07033260n/a1 site๐Ÿ“ Wuhu First Affiliated Hospital of Wannan Medical College ยท Tests: Non-invasive Monitoring Fluid Intake After Hemodialysis NCT04721652n/a2 sites๐Ÿ“ London๐Ÿ“ London London Health Sciences Centre Research Institute OR Lawson โ€ฆ New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients NCT02808572NA7 sites๐Ÿ“ Montpellier๐Ÿ“ Montpellier๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Plasma osteoprotegerin level, Plasma fibroblast growth factor 23 level, Vascular calcification score Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination NCT06635525n/a3 sites๐Ÿ“ Milan๐Ÿ“ Milan๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico ยท Tests: Influenza vaccination, SARS-CoV-2 vaccine Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets) NCT05465044NA8 sites๐Ÿ“ Long Beach๐Ÿ“ West Los Angeles๐Ÿ“ West Haven VA Office of Research and Development ยท Tests: Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule, Thrice-Weekly Hemodialysis Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis NCT07022847n/a1 site๐Ÿ“ Wuhu First Affiliated Hospital of Wannan Medical College ยท Tests: Non-invasive Monitoring Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients NCT06978127NA2 sites๐Ÿ“ Albuquerque๐Ÿ“ Pittsburgh University of Pittsburgh ยท Tests: Technology Assisted Stepped Collaborative Care, Usual Care Arm Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure NCT06676696Phase 41 site๐Ÿ“ Barcelona Hospital Universitari Vall d'Hebron Research Institute ยท Tests: Continue low dose calcineurin inhibitor (CNI), Calcineurin inhibitor withdrawal at 6 months
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy